/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
IMAX Corporation (the Company or IMAX ) is a Canadian corporation that was formed in March 1994 as a result of an amalgamation between WGIM Acquisition Corp. and the former IMAX Corporation ( Predecessor IMAX ). As of December 31, 2025, the Company indirectly owned 71.57% of IMAX China Holding, Inc. ( IMAX China ), whose shares trade on the Hong Kong Stock Exchange.
$51.13
$0.07 (-0.14%)
EOD Sep 1, 2026
20.53% operating margin is above average. ROIC at 11.72%.
Revenue up 16.7% YoY with margins expanding 8.1pp.
At 70x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
70.0x earnings, 22.8x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$415M
▲ +16.7% YoY
Net Income (TTM)
$41M
▲ +33.8% YoY
Op. Margin
20.20%
▲ +8.1pp YoY
ROIC
11.67%
▲ +4.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$127M
▲ +90.5% YoY
Op. Cash Flow (TTM)
$133M
▲ +79.4% YoY
Net Debt
$84M
Cash & Equiv.
$160M
5Y CAGR: +28.2%
Continue Research
SourceComputed from the 10-Q filed 23 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 3 Aug 2026. How this is calculated.
Price from market data, last close as of 1 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 70.0 and a price-to-free-cash-flow of 22.8, Imax (IMAX) trades below a two-stage DCF intrinsic value of about $111.47 per share, so at $51.13 the stock looks undervalued (118.0% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Imax scores 77/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $111.47 per share for IMAX, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $83.61. At today's $51.13, that puts the stock about 118.0% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Imax scores 77 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 20.2% operating margin and a 11.7% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. IMAX currently trades below its estimated intrinsic value and scores 77/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.